These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37679656)

  • 41. Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments.
    Allen LV
    Int J Pharm Compd; 2016; 20(6):495-500. PubMed ID: 28339389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Homogeneity of Two Semisolid Formulations Using Simple In-tube Mixing Method].
    Horisawa E; Asai R; Kondo K; Niwa T
    Yakugaku Zasshi; 2023; 143(6):533-539. PubMed ID: 37258186
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accelerated and Biopredictive In Vitro Release Testing Strategy for Single Agent and Combination Long-Acting Injectables.
    Jain KMH; Ho T; Hoe S; Wan B; Muthal A; Subramanian R; Foti C
    J Pharm Sci; 2024 Jul; 113(7):1885-1897. PubMed ID: 38369022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of mixing procedure itself on the structure, viscosity, and spreadability of white petrolatum and salicylic acid ointment and the skin permeation of salicylic acid.
    Kitagawa S; Fujiwara M; Okinaka Y; Yutani R; Teraoka R
    Chem Pharm Bull (Tokyo); 2015; 63(1):43-8. PubMed ID: 25400272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the coat quality of sustained release pellets by individual pellet dissolution methodology.
    Xu M; Liew CV; Heng PWS
    Int J Pharm; 2015 Jan; 478(1):318-327. PubMed ID: 25435182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interpreting
    Rudd ND; Reibarkh M; Fang R; Mittal S; Walsh PL; Brunskill APJ; Forrest WP
    Mol Pharm; 2020 May; 17(5):1734-1747. PubMed ID: 32267708
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of dissolution profiles for albendazole tablets using USP apparatus 2 and 4.
    Hurtado y de la Peña M; Vargas Alvarado Y; Domínguez-Ramírez AM; Cortés Arroyo AR
    Drug Dev Ind Pharm; 2003 Aug; 29(7):777-84. PubMed ID: 12906335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxygen diffusion coefficients in commonly used topical semisolid creams.
    Wang JC; Ju LK; Ho CS
    Pharm Res; 1988 Feb; 5(2):92-8. PubMed ID: 3247298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro release testing method development for long-acting injectable suspensions.
    Bao Q; Wang X; Zou Y; Wang Y; Burgess DJ
    Int J Pharm; 2022 Jun; 622():121840. PubMed ID: 35595043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation.
    McCarthy CA; Faisal W; O'Shea JP; Murphy C; Ahern RJ; Ryan KB; Griffin BT; Crean AM
    J Control Release; 2017 Mar; 250():86-95. PubMed ID: 28132935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effects of Manufacturing Conditions on Pharmaceutical Properties of Petrolatum Ointment].
    Ashizuka Y; Horisawa E
    Yakugaku Zasshi; 2016 Aug; 136(8):1161-9. PubMed ID: 27193304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of optimal in vitro release and permeation testing method for rectal suppositories.
    Srivatsa Palakurthi S; Bharat Charbe N; Recalde Phillips SY; Alge DL; Lu D; Palakurthi S
    Int J Pharm; 2023 Jun; 640():123042. PubMed ID: 37178789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a flow-through USP 4 apparatus drug release assay for the evaluation of amphotericin B liposome.
    Tang J; Srinivasan S; Yuan W; Ming R; Liu Y; Dai Z; Noble CO; Hayes ME; Zheng N; Jiang W; Szoka FC; Schwendeman A
    Eur J Pharm Biopharm; 2019 Jan; 134():107-116. PubMed ID: 30481559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influencing factors on gelatin matrix for chlorhexidine delivery.
    Murawsky M; Kelm GR; Kozak D; Qin B; Zou Y; Li SK
    Drug Dev Ind Pharm; 2019 Feb; 45(2):314-322. PubMed ID: 30372644
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of in vitro release rates of acyclovir from cream formulations using vertical diffusion cells.
    Nallagundla S; Patnala S; Kanfer I
    AAPS PharmSciTech; 2014 Aug; 15(4):994-9. PubMed ID: 24824173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo.
    Kezutyte T; Drevinskas T; Maruska A; Rimdeika R; Briedis V
    Acta Pol Pharm; 2011; 68(6):965-73. PubMed ID: 22125963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Active compounds release from semisolid dosage forms.
    Olejnik A; Goscianska J; Nowak I
    J Pharm Sci; 2012 Nov; 101(11):4032-45. PubMed ID: 22886492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The mechanism of solifenacin release from a pH-responsive ion-complex oral suspension in the fasted upper gastrointestinal lumen.
    Yamamoto Y; Kumagai H; Haneda M; Vertzoni M; Ouwerkerk N; Murayama D; Katakawa Y; Motonaga K; Reppas C; Tajiri T
    Eur J Pharm Sci; 2020 Jan; 142():105107. PubMed ID: 31669386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus.
    Sager M; Schneider F; Jedamzik P; Wiedmann M; Schremmer E; Koziolek M; Weitschies W
    Mol Pharm; 2017 Dec; 14(12):4272-4280. PubMed ID: 29064257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The release profiles of intact and enzymatically digested hyaluronic acid from semisolid formulations using multi-layer membrane system.
    Alkrad JA; Mrestani Y; Neubert RH
    Eur J Pharm Biopharm; 2003 Jul; 56(1):37-41. PubMed ID: 12837479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.